{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:10:24Z","timestamp":1763766624584,"version":"3.45.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>\n                    Although systemic lupus erythematosus (SLE) and clear cell renal cell carcinoma (ccRCC) are clinically distinct, emerging evidence suggests they may share underlying genetic and immunoregulatory mechanisms. However, the specific molecular basis of their potential comorbidity has not been clearly defined, and no prior study has comprehensively investigated their shared genomic architecture. To fill this critical knowledge gap, we conducted the first integrative genome-wide analysis to identify common susceptibility loci, pleiotropic genes, and convergent biological pathways between SLE and ccRCC. Utilizing large-scale genome-wide association studies summary data from European populations, we employed a combination of methods including LDSC, PLACO, MAGMA, Summary data\u2013based Mendelian randomization , and HyPrColoc, alongside functional annotation and pathway enrichment analyses via FUMA and Metascape. We identified a significant positive genetic correlation between SLE and ccRCC (Rg\u2005=\u20050.287,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20051.5\u2005\u00d7\u200510\n                    <jats:sup>\u22124<\/jats:sup>\n                    ), along with 11 pleiotropic loci, notably including colocalization signals at 3q26.2 and 11q22.3. We further identified 63 pleiotropic genes, with AKT1, ERBB2, and STAT1 functioning as key network hubs associated with the PI3K\/Akt, NF-\u03baB, and JAK-STAT pathways. Immunological colocalization analysis indicated that CD24\u207aIgD\u207aCD38\u207b B cells and unswitched memory B cells may constitute potential comorbid subpopulations. Summary data\u2013based Mendelian randomization analysis further revealed CASP9 as a promising therapeutic target for comorbidity intervention. Overall, this study identified pleiotropic loci and key hub genes enriched in immune-oncogenic pathways, including PI3K\/Akt, NF-\u03baB, and JAK-STAT, and proposed potential therapeutic targets, thereby providing a concrete basis for understanding the comorbidity mechanisms of SLE and ccRCC and informing future precision interventions.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045953","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:01:03Z","timestamp":1763154063000},"page":"e45953","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Revealing the genetic and immunological crosstalk between SLE and ccRCC: An integrative genomic analysis approach"],"prefix":"10.1097","volume":"104","author":[{"given":"Feng","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Shaoxing University, Shaoxing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Shaoxing University, Shaoxing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Shaoxing University, Shaoxing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Shaoxing University, Shaoxing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbo","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Shaoxing University, Shaoxing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2051-1742","authenticated-orcid":false,"given":"Feifei","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Shaoxing University, Shaoxing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","article-title":"Genetic susceptibility to systemic lupus erythematosus in the genomic era.","volume":"6","author":"Deng","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The cancer genome atlas of renal cell carcinoma: findings and clinical implications.","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat Rev Urol"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14737159.2015.1068122","article-title":"BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.","volume":"15","author":"Piva","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1158\/1078-0432.CCR-14-2926","article-title":"Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer.","volume":"21","author":"Giraldo","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases.","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41437-020-0301-4","article-title":"Integration of single nucleotide variants and whole-genome DNA methylation profiles for classification of rheumatoid arthritis cases from controls.","volume":"124","author":"Amiri Roudbar","year":"2020","journal-title":"Heredity (Edinb)"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3390\/biomedicines10123074","article-title":"Interaction of epigallocatechin gallate and quercetin with spike glycoprotein (S-Glycoprotein) of SARS-CoV-2: in silico study.","volume":"10","author":"Alavi","year":"2022","journal-title":"Biomedicines"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/03009742.2017.1384054","article-title":"Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.","volume":"47","author":"Tallbacka","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"860794","DOI":"10.3389\/fonc.2022.860794","article-title":"Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies.","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"R11-20251121","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00432-014-1604-8","article-title":"A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.","volume":"140","author":"Huang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"e000156","DOI":"10.1136\/lupus-2016-000156","article-title":"Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients.","volume":"3","author":"Ramsey-Goldman","year":"2016","journal-title":"Lupus Sci Med"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"e0297861","DOI":"10.1371\/journal.pone.0297861","article-title":"Causal relationship between several autoimmune diseases and renal malignancies: a two-sample mendelian randomization study.","volume":"19","author":"Liu","year":"2024","journal-title":"PLoS One"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits.","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.3211","article-title":"LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41588-024-01725-7","article-title":"Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.","volume":"56","author":"Purdue","year":"2024","journal-title":"Nat Genet"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"e0920","DOI":"10.1212\/NXI.0000000000000920","article-title":"Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS.","volume":"8","author":"Harroud","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/bioinformatics\/btw613","article-title":"LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis.","volume":"33","author":"Zheng","year":"2017","journal-title":"Bioinformatics"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"e1009218","DOI":"10.1371\/journal.pgen.1009218","article-title":"A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between type 2 diabetes and prostate cancer.","volume":"16","author":"Ray","year":"2020","journal-title":"PLoS Genet"},{"key":"R22-20251121","doi-asserted-by":"crossref","first-page":"e1009584","DOI":"10.1371\/journal.pgen.1009584","article-title":"Pleiotropy method reveals genetic overlap between orofacial clefts at multiple novel loci from GWAS of multi-ethnic trios.","volume":"17","author":"Ray","year":"2021","journal-title":"PLoS Genet"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA.","volume":"8","author":"Watanabe","year":"2017","journal-title":"Nat Commun"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajhg.2020.11.012","article-title":"Probabilistic colocalization of genetic variants from complex and molecular traits: promise and limitations.","volume":"108","author":"Hukku","year":"2021","journal-title":"Am J Hum Genet"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41596-022-00745-z","article-title":"Annotating genetic variants to target genes using H-MAGMA.","volume":"18","author":"Sey","year":"2023","journal-title":"Nat Protoc"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R27-20251121","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20251121","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"R29-20251121","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","article-title":"A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits.","volume":"12","author":"Foley","year":"2021","journal-title":"Nat Commun"},{"key":"R30-20251121","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orru","year":"2020","journal-title":"Nat Genet"},{"key":"R31-20251121","doi-asserted-by":"crossref","first-page":"104631","DOI":"10.1016\/j.isci.2022.104631","article-title":"Genetic association and single-cell transcriptome analyses reveal distinct features connecting autoimmunity with cancers.","volume":"25","author":"Li","year":"2022","journal-title":"iScience"},{"key":"R32-20251121","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.ajhg.2024.07.012","article-title":"Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma.","volume":"111","author":"Dutta","year":"2024","journal-title":"Am J Hum Genet"},{"key":"R33-20251121","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.4049\/jimmunol.172.11.7186","article-title":"A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus.","volume":"172","author":"Su","year":"2004","journal-title":"J Immunol"},{"key":"R34-20251121","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/428480","article-title":"Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.","volume":"76","author":"Sigurdsson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R35-20251121","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41431-020-0631-y","article-title":"Inflammasome genetics and complex diseases: a comprehensive review.","volume":"28","author":"Fernandes","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"R36-20251121","doi-asserted-by":"crossref","first-page":"76832","DOI":"10.18632\/oncotarget.20163","article-title":"Genetic variations in TERC and TERT genes are associated with renal cell carcinoma risk in a Chinese Han population.","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"R37-20251121","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3899\/jrheum.081160","article-title":"Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.","volume":"36","author":"Hellquist","year":"2009","journal-title":"J Rheumatol"},{"key":"R38-20251121","doi-asserted-by":"crossref","first-page":"C1417","DOI":"10.1152\/ajpcell.00255.2022","article-title":"The convergence of tumor suppressors on the type I interferon pathway in clear cell renal cell carcinoma and its therapeutic implications.","volume":"323","author":"Langbein","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"R39-20251121","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13543784.2025.2473060","article-title":"A focused report on IFN-1 targeted therapies for lupus erythematosus.","volume":"34","author":"Bhatt","year":"2025","journal-title":"Expert Opin Investig Drugs"},{"key":"R40-20251121","doi-asserted-by":"crossref","first-page":"13222","DOI":"10.1038\/s41598-022-16657-7","article-title":"Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.","volume":"12","author":"Liu","year":"2022","journal-title":"Sci Rep"},{"key":"R41-20251121","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/art.34642","article-title":"Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.","volume":"64","author":"Adrianto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R42-20251121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2007.09.010","article-title":"pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.","volume":"28","author":"Yang","year":"2007","journal-title":"Mol Cell"},{"key":"R43-20251121","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/cells10051184","article-title":"The role of BANK1 in B cell signaling and disease.","volume":"10","author":"Gomez Hernandez","year":"2021","journal-title":"Cells"},{"key":"R44-20251121","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3390\/cancers13164040","article-title":"PI3K\/Akt pathway: the indestructible role of a vintage target as a support to the most recent immunotherapeutic approaches.","volume":"13","author":"Caforio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R45-20251121","doi-asserted-by":"crossref","first-page":"6473038","DOI":"10.1155\/2021\/6473038","article-title":"The role of miR-23b in cancer and autoimmune disease.","volume":"2021","author":"Guo","year":"2021","journal-title":"J Oncol"},{"key":"R46-20251121","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fonc.2020.00584","article-title":"Tumor necrosis factor alpha blockade: an opportunity to tackle breast cancer.","volume":"10","author":"Mercogliano","year":"2020","journal-title":"Front Oncol"},{"key":"R47-20251121","doi-asserted-by":"crossref","first-page":"114760","DOI":"10.1016\/j.bcp.2021.114760","article-title":"Targeting the JAK-STAT pathway in autoimmune diseases and cancers: a focus on molecular mechanisms and therapeutic potential.","volume":"193","author":"Tzeng","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"R48-20251121","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-024-07046-8","article-title":"Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.","volume":"43","author":"Liu","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R49-20251121","doi-asserted-by":"crossref","first-page":"e12894","DOI":"10.1111\/sji.12894","article-title":"Immunogenetics in systemic lupus erythematosus: transitioning from genetic associations to cellular effects.","volume":"92","author":"Hagberg","year":"2020","journal-title":"Scand J Immunol"},{"key":"R50-20251121","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/cancers15061650","article-title":"Role and potential of different T helper cell subsets in adoptive cell therapy.","volume":"15","author":"Andreu-Sanz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R51-20251121","doi-asserted-by":"crossref","first-page":"e007625","DOI":"10.1136\/jitc-2023-007625","article-title":"Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity.","volume":"11","author":"Li","year":"2023","journal-title":"J ImmunoTher Cancer"},{"key":"R52-20251121","doi-asserted-by":"crossref","first-page":"BSR20180992","DOI":"10.1042\/BSR20180992","article-title":"Apoptosis and apoptotic body: disease message and therapeutic target potentials.","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci Rep"},{"key":"R53-20251121","doi-asserted-by":"crossref","first-page":"1502298","DOI":"10.3389\/fphar.2024.1502298","article-title":"The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment.","volume":"15","author":"Guo","year":"2024","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:00:56Z","timestamp":1763766056000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":53,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045953","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-07-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}